Type1diabetes Clinical Trials
Conditions / Type1diabetes
Delta Trials tracks 164 clinical trials for Type1diabetes in its publicly accessible dataset. Among the listed trials, 32 open for participant enrollment and 88 trials have reached completion. This research is carried out at 146 clinical sites around the world. An additional 44 trials have active registrations outside the recruiting and completed categories. Since 2020, 6 trials have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
164
Total Trials
32
Recruiting
88
Completed
44
Other Active
6
Terminated since 2020
146
Study Locations
Browse by location (146 total)
- Montréal, Canada 9 trialsAll trials in Montréal, Canada
- Montréal, Canada 9 trialsAll trials in Montréal, Canada
- Montréal, Canada 9 trialsAll trials in Montréal, Canada
- Milwaukee, United States 7 trialsAll trials in Milwaukee, United States
- Toronto, Canada 6 trialsAll trials in Toronto, Canada
- Boston, United States 6 trialsAll trials in Boston, United States
- Aurora, United States 6 trialsAll trials in Aurora, United States
- New Haven, United States 5 trialsAll trials in New Haven, United States
- Liverpool, United Kingdom 5 trialsAll trials in Liverpool, United Kingdom
- Petah Tikva, Israel 4 trialsAll trials in Petah Tikva, Israel
- Lille, France 4 trialsAll trials in Lille, France
- Toulouse, France 4 trialsAll trials in Toulouse, France
- Paris, France 4 trialsAll trials in Paris, France
- Paris, France 4 trialsAll trials in Paris, France
- Petah-tikva, Israel 4 trialsAll trials in Petah-tikva, Israel
- Uppsala, Sweden 4 trialsAll trials in Uppsala, Sweden
- Corbeil-Essonnes, France 3 trialsAll trials in Corbeil-Essonnes, France
- Reims, France 3 trialsAll trials in Reims, France
- Nancy, France 3 trialsAll trials in Nancy, France
- Minneapolis, United States 3 trialsAll trials in Minneapolis, United States